Little is known about the function of Keratin 80 (KRT80), an epithelial keratin, in cancer. This study investigated the role of KRT80 in the prognosis of colorectal carcinoma (CRC) and the underlying mechanisms involved in CRC migration and invasion. We analyzed the expression of KRT80 using The Cancer Genome Atlas and Oncomine databases. Higher expression of KRT80 was found to be significantly associated with multiple pathological parameters, lower disease-free survival, and overall survival in CRC patients. Also, KRT80 was an independent prognostic indicator for CRC. Furthermore, altered KRT80 expression impacted migration and invasion of CRC cells, as well as the expression of epithelial–mesenchymal transition (EMT)-related markers and cell morphology via the AKT pathway. Inhibiting the expression of AKT could reverse these phenomena. Liquid Chromatograph Mass Spectrometer/Mass Spectromete, Co-immunoprecipitation, and laser scanning confocal microscopy techniques showed that KRT80 could interact with protein kinase, DNA-activated, catalytic polypeptide (PRKDC). Suppressing PRKDC could inhibit the expression of AKT and EMT, as well as the migration and invasion of CRC cells. Taken together, these results demonstrated that KRT80 was an independent prognostic biomarker for CRC and promoted CRC migration and invasion by interacting with PRKDC via activation of the AKT pathway.
DEAD box RNA helicase 17 (DDX17) is a transcriptional regulator of several transcription factors, which is more appreciated than its role in RNA metabolism. However, prognostic value and biofunction of DDX17 in HCC remain unclear. Illuminating the mechanism underlying the regulating HCC progression by DDX17 may contribute to therapeutic strategies. In our study, we report for the first time that DDX17 was overexpressed in HCC specimens by using The Cancer Genome Atlas (TCGA) and immunohistochemistry (IHC) and correlated to clinical pathological characteristics and patients’ survival. In vitro, DDX17 was ascertained to alter HCC migratory and invasive capacities after overexpression and knockdown in HCC cell lines. Moreover, by performing co-immunoprecipitation (Co-IP) and GST-pull down assay, the physical association between DDX17 and Klf4 was discovered and validated. Additionally, DDX17 could modulate expressions of Klf4 target genes including E-cadherin, MMP2 by inhibiting the promoter activity. The potent correlation between DDX17 and Klf4 target gene expressions was further appraised by a same set of 30 HCC tissues. Besides, we discovered that DDX17 could not deploy its function in regulating Klf4 target gene expressions and HCC progression in Klf4-depletion condition. Intriguingly, DDX17 failed to interact with Klf4 once the zinc-finger domain was deleted and inhibited the binding of Klf4 on MMP-2 promoter. Collectively, our study enucleates novel mechanism of DDX17-mediated oncogenesis by suppressing the transcriptional activity of Klf4 thus is likely to be a therapeutic target in HCC.
1 December 2017 in Biochemical and Biophysical Research Communications
Objective: The acquisition of real-time portal vein pressure (PVP) is important for portal hypertension (PH) discrimination to monitor disease progress and select treatment options. To date, the PVP evaluation approaches are either invasive or noninvasive but with less stability and sensitivity. Methods : We customized an open ultrasound scanner to explore in vitro and in vivo the ultrasound contrast agent SonoVue microbubbles’ subharmonic characteristics with acoustic pressure and local ambient pressure, and obtained promising results of PVP measurements in canine models with induced PH by ligation or embolization of portal vein. Results: In in vitro experiments, the highest correlations between the subharmonic amplitude of SonoVue microbubbles and ambient pressure were observed at acoustic pressures of 523 kPa and 563 kPa (r = −0.993, −0.993, P 16 mmHg) diagnostic capacity also achieved a high level (563 kPa, sensitivity = 93.3%, specificity = 91.7%, accuracy = 92.6%). Conclusion: This study proposes a promising measurement for PVP with the highest accuracy, sensitivity, and specificity in an in vivo model compared to existing studies. Future investigations are planned to assess the feasibility of this technique in clinical practice. Significance: This is the first study that comprehensively investigates the role of the subharmonic scattering signals from SonoVue microbubbles in evaluating PVP in vivo. It represents a promising alternative to invasive measurements for portal pressure.
Background: Choriocarcinoma is a rare and highly aggressive trophoblastic tumor. Although in-depth research has been conducted on the treatment options for choriocarcinoma, especially chemotherapy regimens, there are still 10% to 20% of choriocarcinoma patients who develop resistance or experience tumor recurrence. The research on the pathogenesis of choriocarcinoma and its treatment remains a major challenge and an unresolved clinical issue. Accurately replicating the key characteristics of choriocarcinoma in preclinical tumor models is crucial for research into tumor mechanisms and treatment. Up to now, the lack of a universal in vitro model required for studying tumor-related diseases is a key problem faced by researchers. It is notable that three-dimensional bioprinting (3DP) technology has seen expanding utilization across multiple domains of biomedical research. To this end, we aimed to employ 3DP technology to construct an in vitro choriocarcinoma model and to comprehensively compare it with conventional two-dimensional (2D) culture systems in multiple aspects. Methods: A 3DP approach was employed to generate an in vitro choriocarcinoma model, and the cells in this model were comprehensively compared with those in traditional 2D cultured cells. A fluorescence live/dead kit was used to assess cell viability. Proliferation of JEG-3 cells was assessed by the Cell Counting Kit-8 (CCK-8) assay. We also analyzed the gene expression of 2D and 3D bioprinted cells. Finally, we used antitumor drugs to conduct drug response tests on the cells in the 2D and 3DP groups. Results: The cells in the 3DP system exhibited stronger vitality, metabolic activity, and key tumor biological characteristics, compared to the cells cultured in a single layer in the 2D cultures. Throughout the entire observation window, JEG-3 cells in the 3D bioprinted model proliferated more robustly, suggesting that the 3D bioprinted environment supports sustained cell growth and is suitable for long-term experiments. Cells in the 3D bioprinted model exhibited significantly higher levels of genes associated with proliferation, metastasis, drug resistanace, immune suppression, and epithelial-to-mesenchymal transition (EMT), compared to those cultured in 2D. We also found that the 3D bioprinted model released markedly greater amounts of human chorionic gonadotropin (hCG) than the 2D culture. The results of drug screening assays indicated that the half-maximal inhibitory concentration (IC50) values for three tested chemotherapeutic agents were substantially elevated in the 3D bioprinted model relative to the 2D model. Conclusions: This study demonstrates the feasibility of engineering a 3D bioprinted tumor model using a composite hydrogel system to mimic the in vivo tumor microenvironment more effectively. The 3D bioprinted microtissue model provides a realistic platform for studying cancer cell behavior and holds significant promise for preclinical applications, particularly in advancing our understanding of choriocarcinoma. This approach is adaptable to other tumor types and could significantly contribute to the development of personalized therapeutic strategies.